Dr. Torsten Hoffmann is a Senior Drug Discovery Consultant with a extensive background in medicinal chemistry, pharmacology, and toxicology. They held significant leadership roles, including Senior Vice President of Drug Discovery at Taros Chemicals and Chief Scientific Officer at Zealand Pharma and Silence Therapeutics plc. Currently, they serve on the Scientific Advisory Boards of ZeCardio Therapeutics and BioSolveIT, while continuing their consultancy work in drug discovery. Dr. Hoffmann's academic journey includes training at The Scripps Research Institute.
This person is not in the org chart
This person is not in any teams
This person is not in any offices